Trials / Conditions / Hypertrophy, Left Ventricular

Hypertrophy, Left Ventricular

21 registered clinical trials studyying Hypertrophy, Left Ventricular.

Status	Trial	Sponsor	Phase
Completed	Effect of a Targeted Notification and Clinical Support Pathway on Individuals With Left Ventricular Hypertroph NCT05713916	Massachusetts General Hospital	N/A
Withdrawn	Efficacy of Angiotensin Receptor Blocker Following aortIc Valve Intervention for Aortic STenOsis: a Randomized NCT03315832	University Hospital, Limoges	Phase 2 / Phase 3
Completed	CMR T1 Mapping for Diagnosis of Cardiac Amyloidosis NCT04862273	University of Leipzig	—
Completed	Predictors of Left Ventricular Hypertrophy in Hypertensive Patients in Assiut Governorate NCT03482934	Assiut University	—
Completed	Towards Understanding the Phenotype of Cardiovascular Disease in CKD - TRUE-Type-CKD Study NCT03749551	Johann Wolfgang Goethe University Hospital	—
Active Not Recruiting	Early Valve Replacement Guided by Biomarkers of LV Decompensation in Asymptomatic Patients With Severe AS NCT03094143	University of Edinburgh	N/A
Completed	Effects of a Reduction in Renal Function on Cardiovascular Structure and Function NCT02973607	University Hospital Birmingham NHS Foundation Trust	—
Completed	Efficacy and Safety of Valsartan and Nebivolol/Valsartan in Hypertensive Patients With LVH NCT03180593	Trinity Hypertension & Metabolic Research Institute	Phase 4
Completed	Everolimus and Tacrolimus Combination for Regression of Left Ventricular Hypertrophy in Renal Transplants NCT03415750	Edoardo Melilli	Phase 4
Completed	Assessment of Efficacy of Mirabegron, a New beta3-adrenergic Receptor in the Prevention of Heart Failure NCT02599480	Jean-Luc Balligand	Phase 2
Completed	EMPower: Electronic Media Powering Positive Health Changes in Youth NCT02444689	Johns Hopkins University	N/A
Completed	Does Allopurinol Reduce Thickening of the Left Ventricle of the Heart in Patient With Treated Hypertension? NCT02237339	University of Dundee	Phase 4
Completed	New-onset Diabetes and Left Ventricular Hypertrophy in Renal Transplantation NCT01976689	Baskent University	—
Unknown	Myocardial Protection With Perhexiline in Left Ventricular Hypertrophy NCT00989508	University Hospital Birmingham	Phase 2 / Phase 3
Terminated	The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects Wit NCT00616902	Abbott	Phase 3
Unknown	Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With NCT00552851	University of Wuerzburg	Phase 4
Completed	Glutamate and Diastolic Function in Patients Undergoing Aortic Valve Repair NCT01144039	Medical University of Vienna	Phase 4
Completed	The CLEVER Study - Coreg And Left Ventricular Mass Regression NCT00108082	GlaxoSmithKline	Phase 3
Completed	Cardiac MR of Subclinical CVD: Impact of Age NCT00041418	National Heart, Lung, and Blood Institute (NHLBI)	—
Completed	The SILVER Study: Systolic Hypertension Interaction With Left Ventricular Remodeling NCT00045994	Synvista Therapeutics, Inc	Phase 2
Completed	Racial Differences in the Coronary Microcirculation NCT00005373	National Heart, Lung, and Blood Institute (NHLBI)	—